Target intelligence / Profile preview

TUSC2 pseudogene 2 (TUSC2P2)

Target
TUSC2P2
Molecular classification
Other (Pseudogene)
01

Overview

TUSC2 pseudogene 2 (TUSC2P2) is classified as a pseudogene, meaning it is a DNA sequence resembling the gene for the protein tumor suppressor candidate 2 (TUSC2) but does not encode a functional protein. Pseudogenes like TUSC2P2 can have regulatory functions at the RNA level. TUSC2P2 and related pseudogene transcripts are known to act as *competing endogenous RNAs (ceRNAs)* that sequester microRNAs (miRNAs), thereby modulating the translation of TUSC2 and other genes involved in tumor suppression. While TUSC2P2 shows altered expression in normal versus cancer cells and may regulate tumor suppressor pathways indirectly, it is not itself considered a therapeutic target, receptor, enzyme, transporter, or drug-binding molecule. There is no evidence for direct drug interactions or use as a clinical biomarker. TUSC2 (the protein-coding gene) is a well-known tumor suppressor involved in apoptosis, cell proliferation, and mitochondrial regulation, but TUSC2P2 is a non-functional pseudogene with potential regulatory effects only through miRNA binding and does not encode a protein or receptor. This information is specific to TUSC2P2; misspellings or confusion may arise due to the close similarity to TUSC2, but they refer to distinct genomic entities.

Other names
TUSC2P2TUSC2 pseudogene 2
02

Mechanism of action

Not applicable for TUSC2P2; it functions through modulation of miRNA activity as non-coding RNA, not as a direct drug target

03

Biological functions

Competing endogenous RNA: binds microRNAs and modulates mRNA translation of related genes such as TUSC2, TIMP2, and TIMP3 by “sponging” miRNAsPotential regulation of cell proliferation, apoptosis, migration, and invasion in experimental systems through non-coding RNA mechanisms
04

Disease associations

Cancer: Indirectly implicated in the regulation of genes involved in tumor suppression and cancer cell biology due to its competing endogenous RNA activity, but it is not itself a protein-coding gene or direct drug target

Beyond the preview

Go deeper on TUSC2 pseudogene 2 (TUSC2P2).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on TUSC2 pseudogene 2 (TUSC2P2).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call